BACTEREMIA DUE TO STENOTROPHOMONAS MALTOPHILIA – A SERIES OF THREE CASES

---

Case Report

Author Details : Ranjana Hawaldar, Sadhna Sodani

Volume : 2, Issue : 2, Year : 2015

Article Page : 128-132

Suggest article by email

Get Permission

---

Abstract

Bacteremia due to Stenotrophomonas maltophilia – a series of three cases. Stenotrophomonas maltophilia is an aerobic ubiquitous gram-negative bacillus that has been isolated from humans, animals, soil, food, and pharmaceuticals. Because of its limited invasiveness and low level of pathogenicity, it is rarely responsible for community-acquired serious infections. In recent years, S. maltophilia has been increasingly reported as a cause of life-threatening infections, in particular in immune compromised patients. Antimicrobial pressure, indwelling venous catheterization, long-term hospitalization, aggressive. Cytoreductive treatments for malignancy and neutropenia seem to be contributory factors. Management is problematic because of resistance to commonly used antibiotics including those of carbapenem class. In vitro susceptibility testing specific guidelines are not available for management. The development of rapid, inexpensive and reproducible culture systems such as Vitek II has made possible the recognition of this as a cause of bacteremia. In particular more information on nosocomial reservoirs and routes of transmission of the bacterium is needed for effective infection control strategies. Here we report a series of three cases of Stenotrophomonas maltophilia bacteremia from patients admitted in a paediatric ICU.

Key Words: Stenotrophomonas maltophilia, Bacteremia, Nosocomial infection

How to cite : Hawaldar R, Sodani S, BACTEREMIA DUE TO STENOTROPHOMONAS MALTOPHILIA – A SERIES OF THREE CASES. Indian J Microbiol Res 2015;2(2):128-132

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.